CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies

✍ Scribed by Holtan, S G; Hogan, W J; Elliott, M A; Ansell, S M; Inwards, D J; Porrata, L F; Johnston, P B; Micallef, I N; Lacy, M Q; Gastineau, D A

• Book ID: 109840961
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 257 KB
• Volume: 45
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/bmt.2010.49